← Earnings Calendar
Coverage News Earnings Hub Grades Earnings Report
GALT Q2 2026
Galectin Therapeutics Inc
Biotechnology
—
No Grade
⚠️
Significant Miss
Actual $-0.08 vs Est $-0.06
-30.7%
📊 EPS Scorecard
EPS Estimate
$-0.06
EPS Actual
$-0.08
Surprise
-30.7%
Period2026-03-31
QuarterQ2 2026
📈 EPS Momentum — Last 4 Quarters
$-0.12
25-06
$-0.13
25-09
$-0.08
25-12
$-0.08
26-03
📈 +33% over 4 quarters
🤖 ESEN AI Grade Reasoning
🔒 AI Grade Reasoning Unlock with PLUS
🔗 Other GALT Earnings
GALT
Q1 2026
→ View
GALT
Q3 2026
→ View
GALT
Q4 2026
→ View
GALT
Full Research
→ Stock Page
Unlock Full Earnings Analysis
AI grade reasoning, momentum alerts, and full analysis for 5,000+ stocks
Start PLUS — First Month $4.99
Then $19.99/month · Cancel anytime